These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25355921)

  • 41. Differential escape of HCV from CD8
    Xia Y; Pan W; Ke X; Skibbe K; Walker A; Hoffmann D; Lu Y; Yang X; Feng X; Tong Q; Timm J; Yang D
    J Viral Hepat; 2019 Jan; 26(1):73-82. PubMed ID: 30260541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors.
    Zhang H; Zhang J; Chen L; Weng Z; Tian Y; Zhao H; Li Y; Chen L; Liang Z; Zheng H; Zhao W; Zhong S; Li Y
    J Gen Virol; 2017 Mar; 98(3):374-384. PubMed ID: 27902325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.
    Schmidt J; Iversen AK; Tenzer S; Gostick E; Price DA; Lohmann V; Distler U; Bowness P; Schild H; Blum HE; Klenerman P; Neumann-Haefelin C; Thimme R
    PLoS Pathog; 2012; 8(11):e1003042. PubMed ID: 23209413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERAP1 allotypes shape the epitope repertoire of virus-specific CD8
    Kemming J; Reeves E; Nitschke K; Widmeier V; Emmerich F; Hermle T; Gostick E; Walker A; Timm J; Price DA; Hofmann M; Thimme R; James E; Neumann-Haefelin C
    J Hepatol; 2019 Jun; 70(6):1072-1081. PubMed ID: 30769005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modification.
    Huang YH; Wu JC; Peng WL; Huo TI; Shih HH; Lan KH; Su CW; Lee SD
    J Hepatol; 2009 Apr; 50(4):779-88. PubMed ID: 19243853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.
    Yusim K; Fischer W; Yoon H; Thurmond J; Fenimore PW; Lauer G; Korber B; Kuiken C
    J Gen Virol; 2010 May; 91(Pt 5):1194-206. PubMed ID: 20053820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.
    Guglietta S; Garbuglia AR; Salichos L; Ruggeri L; Folgori A; Perrone MP; Camperio C; Mellace V; Maio G; Maio P; Capobianchi MR; Spada E; Gargano N; Scottà C; Piccolella E; Del Porto P
    Virology; 2009 Apr; 386(2):398-406. PubMed ID: 19232664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes.
    Ziegler S; Ruhl M; Tenckhoff H; Wiese M; Heinemann FM; Horn PA; Spengler U; Neumann-Haefelin C; Nattermann J; Timm J;
    J Hepatol; 2013 Jan; 58(1):24-30. PubMed ID: 22925811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants.
    Deng S; Xu Z; Wang M; Hu J; Liu Z; Zhu F; Zheng P; Kombe Kombe AJ; Zhang H; Wu S; Jin T
    J Biol Chem; 2024 Aug; 300(8):107563. PubMed ID: 39002680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man.
    Bowen DG; Walker CM
    J Exp Med; 2005 Jun; 201(11):1709-14. PubMed ID: 15939787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.
    Pasetto A; Frelin L; Brass A; Yasmeen A; Koh S; Lohmann V; Bartenschlager R; Magalhaes I; Maeurer M; Sällberg M; Chen M
    J Gen Virol; 2012 Feb; 93(Pt 2):247-258. PubMed ID: 22071510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
    von Delft A; Humphreys IS; Brown A; Pfafferott K; Lucas M; Klenerman P; Lauer GM; Cox AL; Gaudieri S; Barnes E
    Gut; 2016 Jan; 65(1):112-23. PubMed ID: 26092843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.
    Prabdial-Sing N; Puren AJ; Bowyer SM
    BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes.
    Clute SC; Naumov YN; Watkin LB; Aslan N; Sullivan JL; Thorley-Lawson DA; Luzuriaga K; Welsh RM; Puzone R; Celada F; Selin LK
    J Immunol; 2010 Dec; 185(11):6753-64. PubMed ID: 21048112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.
    Ladell K; Hashimoto M; Iglesias MC; Wilmann PG; McLaren JE; Gras S; Chikata T; Kuse N; Fastenackels S; Gostick E; Bridgeman JS; Venturi V; Arkoub ZA; Agut H; van Bockel DJ; Almeida JR; Douek DC; Meyer L; Venet A; Takiguchi M; Rossjohn J; Price DA; Appay V
    Immunity; 2013 Mar; 38(3):425-36. PubMed ID: 23521884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression.
    van den Heuvel H; Heutinck KM; van der Meer-Prins EMW; Franke-van Dijk MEI; van Miert PPMC; Zhang X; Ten Berge IJM; Claas FHJ
    Hum Immunol; 2018 Jan; 79(1):39-50. PubMed ID: 29100943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.
    Kjer-Nielsen L; Clements CS; Brooks AG; Purcell AW; Fontes MR; McCluskey J; Rossjohn J
    J Immunol; 2002 Nov; 169(9):5153-60. PubMed ID: 12391232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.